Literature DB >> 1967432

Rejection of bone-marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigens.

P J Voogt1, W E Fibbe, W A Marijt, E Goulmy, W F Veenhof, M Hamilton, A Brand, F E Zwann, R Willemze, J J van Rood.   

Abstract

A female patient showed rejection of a T-lymphocyte-depleted bone-marrow graft from her phenotypically HLA-identical father. Before bone-marrow transplantation, there was strong recipient anti-donor cellular cytotoxic reactivity directed against several minor histocompatibility (mH) antigens, including the male-specific H-Y antigen. After conditioning treatment, no recipient anti-donor cytotoxic activity could be detected, and good graft function was shown a month after transplantation. Thereafter, however, graft function deteriorated rapidly, while recipient-derived anti-donor cellular cytotoxic reactivity, against similar mH antigens, reappeared. The recipient-derived cytotoxic T lymphocytes could completely inhibit growth of donor haemopoietic progenitor cells both before and after bone-marrow transplantation. Thus, cytotoxic T lymphocytes can survive very intensive conditioning regimens, and residual recipient cytotoxic T lymphocytes directed against mH antigens expressed on donor haemopoietic progenitor cells may cause graft rejection after HLA-identical T-lymphocyte-depleted bone-marrow transplantation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1967432     DOI: 10.1016/0140-6736(90)90003-n

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  15 in total

1.  Integration of humoral and cellular HLA-specific immune responses in cord blood allograft rejection.

Authors:  R Hanajiri; M Murata; K Sugimoto; M Murase; R Sakemura; T Goto; K Watanabe; N Imahashi; S Terakura; H Ohashi; Y Akatsuka; S Kurahashi; K Miyamura; H Kiyoi; T Nishida; T Naoe
Journal:  Bone Marrow Transplant       Date:  2015-06-01       Impact factor: 5.483

2.  Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia.

Authors:  W A Erik Marijt; Mirjam H M Heemskerk; Freke M Kloosterboer; Els Goulmy; Michel G D Kester; Menno A W G van der Hoorn; Simone A P van Luxemburg-Heys; Manja Hoogeboom; Tuna Mutis; Jan Wouter Drijfhout; Jon J van Rood; Roel Willemze; J H Frederik Falkenburg
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-24       Impact factor: 11.205

3.  Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors.

Authors:  David B Miklos; Haesook T Kim; Emmanuel Zorn; Ephraim P Hochberg; Luxuan Guo; Alex Mattes-Ritz; Sebastien Viatte; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Journal:  Blood       Date:  2003-09-25       Impact factor: 22.113

4.  H-Y antibody development associates with acute rejection in female patients with male kidney transplants.

Authors:  Jane C Tan; Persis P Wadia; Marc Coram; F Carl Grumet; Neeraja Kambham; Katherine Miller; Shalini Pereira; Tamara Vayntrub; David B Miklos
Journal:  Transplantation       Date:  2008-07-15       Impact factor: 4.939

5.  Antigens shared by malignant plasma cells and normal B cells may be involved in graft versus myeloma.

Authors:  P A Holloway; N Kaldenhoven; H M Kok-Schoemaker; B Van Kessel; W T M Van Blokland; A C Bloem; H M Lokhorst
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

6.  Peripheral host T cells survive hematopoietic stem cell transplantation and promote graft-versus-host disease.

Authors:  Sherrie J Divito; Anders T Aasebø; Tiago R Matos; Pei-Chen Hsieh; Matthew Collin; Christopher P Elco; John T O'Malley; Espen S Bækkevold; Henrik Reims; Tobias Gedde-Dahl; Michael Hagerstrom; Jude Hilaire; John W Lian; Edgar L Milford; Geraldine S Pinkus; Vincent T Ho; Robert J Soiffer; Haesook T Kim; Martin C Mihm; Jerome Ritz; Indira Guleria; Corey S Cutler; Rachael A Clark; Frode L Jahnsen; Thomas S Kupper
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

7.  H-Y incompatibility predicts short-term outcomes for kidney transplant recipients.

Authors:  S Joseph Kim; John S Gill
Journal:  J Am Soc Nephrol       Date:  2009-06-18       Impact factor: 10.121

8.  Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes.

Authors:  L M Faber; J van der Hoeven; E Goulmy; A L Hooftman-den Otter; S A van Luxemburg-Heijs; R Willemze; J H Falkenburg
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

9.  Immunodeficiency in RFM/(T6xRFM)F1 mouse chimaeras with lethal host-versus-graft syndrome.

Authors:  R C Hard; J L Montour; B A Fuchs
Journal:  Clin Exp Immunol       Date:  1995-05       Impact factor: 4.330

10.  H-Y Antigen Incompatibility Not Associated with Adverse Immunologic Graft Outcomes: Deceased Donor Pair Analysis of the OPTN Database.

Authors:  Douglas Scott Keith; James T Patrie
Journal:  J Transplant       Date:  2011-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.